esc

Type at least two characters to start searching.

select openesc close

Share

Export Citation

APA
MLA
Chicago
Harvard
Vancouver
BIBTEX
RIS
Universitas Hasanuddin
Research output:Contribution to journalArticlepeer-review

Leptin Expression in High-Grade Serous Ovarian Carcinoma: The Controversy of Leptin Paradox in Ovarian Cancer

Ham J.

Indonesian Journal of Obstetrics and Gynecology

Q4
Published: 2025

Abstract

Objectives : To analyse the characteristics and expression patterns of Leptin in high-grade serous epithelial ovarian carcinoma (HGSC), and to compare them with the overall serous ovarian carcinoma population. Methods : This was a cross-sectional study. A total of 77 paraffin-embedded tissue samples were collected from patients at the Wahidin Sudirohusodo Hospital over a period of 3 years. Immunohistochemical staining was performed using a polyclonal Leptin antibody. Data were analyzed using SPSS version 22.0. Results: Among HGSC patients, the majority (64.3%) were over 50 years old, and a significant portion (39.3%) were obese. Leptin showed strong cytoplasmic expression in 69.6% of HGSC tumor cells and in 100% of LGSC tumor cells (p-value = 0.004). There was no correlation between lymphovascular space invasion and leptin expression. Interestingly, leptin expression in overall serous ovarian carcinoma patients exhibited a protective effect against metastasis (p-value = 0.047), suggesting a leptin paradox exists in this type of cancer. However, this association was no longer significant when the analysis excluded the LGSC group (p-value = 0.193). Conclusion : This study suggest that leptin expression may not be a significant prognostic factor in HGSC. The appearance of the pseudo-leptin paradox phenomenon in several previous studies was confounded by sample populations with heterogeneous tumor morphology. Keywords: high-grade serous carcinoma, leptin paradox, immunohistochemistry, leptin, obesity

Access to Document

10.32771/inajog.v13i1.2373

Other files and links

Fingerprint

LeptinSciences
MedicineSciences
Serous carcinomaSciences
ImmunohistochemistrySciences
Serous fluidSciences
Ovarian cancerSciences
Internal medicineSciences
Ovarian carcinomaSciences
PopulationSciences
OncologySciences
Serous ovarian cancerSciences
CancerSciences
MetastasisSciences
PathologySciences
EndocrinologySciences
ObesitySciences
Environmental healthSciences